immunosuppressive therapy

  • 网络免疫抑制治疗;免疫抑制疗法;和免疫抑制疗法
immunosuppressive therapyimmunosuppressive therapy
  1. Objective To study immunosuppressive therapy after multiple organ transplantation .

    目的探讨多器官联合移植术后的免疫抑制治疗方法。

  2. Object : To discuss the rational supporting individualized titration of immunosuppressive therapy .

    目的:探讨个体化免疫抑制治疗的依据。

  3. AIM To explore the immunosuppressive therapy for post liver transplantation .

    目的探讨肝移植术后的免疫抑制疗法。

  4. Decision Tree Analysis of Immunosuppressive Therapy After Renal Transplantation

    肾移植免疫抑制治疗方案的决策树分析

  5. Long-term evaluation of FK506 based immunosuppressive therapy in kidney transplantation

    肾移植术后长期应用他克莫司的临床观察

  6. Prediction on Response of Immunosuppressive Therapy in Patients with Aplastic Anemia

    再生障碍性贫血免疫抑制治疗疗效预测

  7. Immunosuppressive therapy for 2 patients with liver transplantation

    肝移植2例的免疫抑制疗法

  8. Combined immunosuppressive therapy of childhood severe aplastic anemia with multiple agents

    多种免疫抑制剂联合治疗儿童重型再生障碍性贫血

  9. Thomas cardioplegia and the new immunosuppressive therapy was taken postoperatively .

    术后采用新的三联免疫抑制治疗。

  10. No additional immunosuppressive therapy was applied .

    然后不进行其他的免疫抑制治疗。

  11. Clinical Analysis of 15 Cases of Herpes Zoster Complicated in SLE Patients Treated with Immunosuppressive Therapy

    免疫抑制治疗系统性红斑狼疮时并发带状疱疹15例临床分析

  12. Clinical Analysis of the Efficacy of Intensive Immunosuppressive Therapy in 68 Children With Severe Aplastic Anemia

    68例儿童重型再生障碍性贫血强化免疫抑制治疗的疗效分析

  13. Immunosuppressive therapy is effective on autoimmune hepatitis .

    免疫抑制治疗有效。

  14. Immunosuppressive therapy for children with acute aplastic anemia

    免疫抑制剂治疗儿童急性再生障碍性贫血的初步效果

  15. Immunosuppressive therapy for pure red cell aplasia and aplastic anemia

    纯红细胞再生障碍和再生障碍性贫血的免疫抑制治疗

  16. Conclusions : Results indicate that ① immunosuppressive therapy reactivates latent HCMV infection ;

    结论:研究结果显示:①免疫抑制治疗激活了潜伏性HCMV感染,导致术后HCMV含量显著增加;

  17. Renal failure at presentation carries an increased risk for ESRD and death despite immunosuppressive therapy .

    即使接受免疫抑制治疗,发病时出现肾衰也会增加发生ESRD的风险。

  18. Immunosuppressive therapy after multiple organ transplantation

    多器官联合移植的免疫抑制治疗

  19. The immunosuppressive therapy of liver transplantation

    肝移植的免疫抑制治疗

  20. This finding may help identify other transplant recipients who could safely reduce or end use of immunosuppressive therapy .

    这个发现可能有助于确定能安全地减少或停止使用免疫抑制疗法的其他移植受者。

  21. Sequential intensified immunosuppressive therapy combining with hematopoietic growth factors in the treatment of severe aplastic anemia

    序贯强化免疫抑制并用造血生长因子治疗重型再生障碍性贫血

  22. The daclizumab and triple drug therapy was adopted for postoperative immunosuppressive therapy .

    免疫抑制治疗采用赛尼哌加三联方案。

  23. 17 cases of SLE had been tested on admission and 3 months after treatment with immunosuppressive therapy .

    对17例SLE患者入院及治疗3个月后行ACA滴度对比。

  24. For these limitations , it is necessary to find other tools to improve interindividual immunosuppressive therapy .

    对于这些限制,有必要寻找其他的方法来达到个体化免疫抑制治疗。

  25. Conclusion The immunosuppressive therapy using blocking antibodies is of great clinical significance and value for infertility and habitual abortion .

    结论封闭抗体免疫疗法治疗免疫性不孕症及习惯性流产具有重要的临床意义和应用价值。

  26. A cholinesterase inhibitor ( ChEI ) and immunosuppressive therapy were applied for treatment .

    一种胆碱酯酶抑制剂和免疫抑制疗法用于治疗。

  27. Membranous nephropathy is refractory nephrotic syndrome , no recognized treatment plan , the treatment is immunosuppressive therapy .

    膜性肾病属于难治性肾病综合征,尚无公认的治疗方案,目前治疗主要是免疫抑制治疗。

  28. Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy in patients with glomerulonephritis

    肾小球肾炎患者免疫抑制治疗后并发卡氏肺孢子虫肺炎

  29. Immunosuppressive therapy in pediatric cadaveric renal transplantation

    儿童肾移植临床免疫抑制用药探讨

  30. Objective : To explore the feasibility , efficacy , and safety of high-dose immunosuppressive therapy in patients with autoimmune diseases .

    目的:探讨大剂量化疗治疗自身免疫性疾病的可行性、疗效以及安全性。